LMNL

Liminal BioSciences (LMNL)

Liminal BioSciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LMNL

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/10/06	21:30	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/28	05:05	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/27	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/27	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/27	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/26	22:12	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/26	22:08	Edgar (US Regulatory)	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/26	22:07	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/26	22:04	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/26	21:57	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/26	21:55	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/26	21:54	Edgar (US Regulatory)	Form SC 13E3/A - Going private transaction by certain issuers: [Amend]	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/26	21:16	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/26	21:00	PR Newswire (US)	LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/26	21:00	PR Newswire (Canada)	LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/20	05:43	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/20	05:34	PR Newswire (US)	LIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/20	05:22	PR Newswire (Canada)	LIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/20	05:22	PR Newswire (US)	LIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/16	01:03	PR Newswire (US)	LIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/16	01:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/16	00:29	PR Newswire (US)	LIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/16	00:29	PR Newswire (Canada)	LIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/12	21:38	Edgar (US Regulatory)	Form SC 13E3/A - Going private transaction by certain issuers: [Amend]	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/12	21:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/12	21:02	PR Newswire (US)	LIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND SUPPLEMENT TO THE MANAGEMENT INFORMATION CIRCULAR	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/12	20:45	PR Newswire (Canada)	LIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND SUPPLEMENT TO THE MANAGEMENT INFORMATION CIRCULAR	NASDAQ:LMNL	Liminal BioSciences Inc
2023/09/12	20:45	PR Newswire (US)	LIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND SUPPLEMENT TO THE MANAGEMENT INFORMATION CIRCULAR	NASDAQ:LMNL	Liminal BioSciences Inc
2023/08/17	06:20	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:LMNL	Liminal BioSciences Inc
2023/08/17	06:20	PR Newswire (US)	LIMINAL BIOSCIENCES OBTAINS INTERIM ORDER FOR PROPOSED ARRANGEMENT WITH STRUCTURED ALPHA LP	NASDAQ:LMNL	Liminal BioSciences Inc